GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 75 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $86,000 | +138.9% | 28,155 | +55.1% | 0.01% | +140.0% |
| Q1 2020 | $36,000 | -30.8% | 18,155 | 0.0% | 0.01% | -16.7% |
| Q4 2019 | $52,000 | -22.4% | 18,155 | 0.0% | 0.01% | -33.3% |
| Q3 2019 | $67,000 | 0.0% | 18,155 | +12.9% | 0.01% | -10.0% |
| Q2 2019 | $67,000 | -18.3% | 16,080 | 0.0% | 0.01% | -28.6% |
| Q1 2019 | $82,000 | +127.8% | 16,080 | +52.7% | 0.01% | +100.0% |
| Q4 2018 | $36,000 | -40.0% | 10,530 | +5.0% | 0.01% | -46.2% |
| Q3 2018 | $60,000 | +114.3% | 10,030 | +47.9% | 0.01% | +62.5% |
| Q1 2018 | $28,000 | -17.6% | 6,780 | 0.0% | 0.01% | -11.1% |
| Q4 2017 | $34,000 | +240.0% | 6,780 | +69.5% | 0.01% | +125.0% |
| Q3 2017 | $10,000 | -56.5% | 4,000 | 0.0% | 0.00% | -63.6% |
| Q2 2017 | $23,000 | +155.6% | 4,000 | 0.0% | 0.01% | +83.3% |
| Q1 2017 | $9,000 | +350.0% | 4,000 | +100.0% | 0.01% | +200.0% |
| Q4 2016 | $2,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 129,488 | $271,925 | 0.08% |
| Geneos Wealth Management Inc. | 427,400 | $897,540 | 0.06% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $25,200 | 0.02% |
| Vivaldi Capital Management LP | 19,261 | $40,448 | 0.01% |
| Beacon Capital Management, LLC | 12,605 | $26,471 | 0.01% |
| Atria Wealth Solutions, Inc. | 263,300 | $552,930 | 0.01% |
| Wealthspire Advisors, LLC | 183,862 | $386,111 | 0.01% |
| BARRETT & COMPANY, INC. | 4,984 | $10,466 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,271,760 | $2,670,656 | 0.01% |
| Ameritas Advisory Services, LLC | 45,302 | $94,856 | 0.01% |